Ciloa is able to develop exosomal platforms harboring different membrane proteins simultaneously.
New techniques to find new therapies
Exosomes originate from membrane budding. After release they can interact with new cells and fuse back to their membranes, delivering new proteins to these cells. This phenomenon can be used to target specific cells with particular proteins. Thus, you can use the Ciloa solution, for example, to target cancer cells with exosomes harboring toxic molecules or molecules recruiting the immune system.
Ciloa is able to tailor exosomes to harbor two or more different proteins in order to develop new kind of therapies.